Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Not applicable Interventional

Evaluation of the Safety and Efficacy of TLD in Patients with COPD

ClinicalTrials.gov ID: NCT03639051

Public ClinicalTrials.gov record NCT03639051. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 12:22 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Sham-controlled Study to Evaluate Safety and Efficacy After Treatment with the Nuvaira™ Lung Denervation System in Patients with Chronic Obstructive Pulmonary Disease (COPD)

Study identification

NCT ID
NCT03639051
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Not applicable
Lead sponsor
Nuvaira, Inc.
Industry
Enrollment
464 participants

Conditions and interventions

Conditions

Interventions

  • Targeted Lung Denervation (TLD) Device
  • Optimal Medical Care Other

Device · Other

Eligibility (public fields only)

Age range
40 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 22, 2019
Primary completion
Sep 30, 2024
Completion
Aug 31, 2028
Last update posted
Nov 13, 2024

2019 – 2028

United States locations

U.S. sites
20
U.S. states
14
U.S. cities
20
Facility City State ZIP Site status
University of Alabama at Birmingham (UAB) Lung Health Center Birmingham Alabama 35294
HonorHealth Phoenix Arizona 85258
UC Davis Sacramento California 95817
Harbor UCLA Torrance California 90502
Ascension St. Vincent's Jacksonville Florida 32204
University of Chicago Chicago Illinois 60637
Suburban Lung Associates Elk Grove Village Illinois 60007
University of Louisville Louisville Kentucky 40202
Lahey Hospital & Medical Center Burlington Massachusetts 01805
University of Michigan Ann Arbor Michigan 48109
Spectrum Health Medical Group Grand Rapids Michigan 49546
Washington University St Louis Missouri 63110
Duke University Durham North Carolina 27710
First Health of the Carolinas Pinehurst North Carolina 28374
Ohio State University Wexner Medical Center Columbus Ohio 43210
Temple Lung Center Philadelphia Pennsylvania 19140
University of Pittsburgh Medical Center (UPMC) Pittsburgh Pennsylvania 15219
Medical University of South Carolina (MUSC) Charleston South Carolina 29425
St. Davids HealthCare Georgetown Texas 78626
Houston Methodist Hospital Houston Texas 77030

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 13 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03639051, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 13, 2024 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03639051 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →